{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:47:24Z","timestamp":1792788444670,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Medical Research Project of Yancheng Municipal Health Commission","award":["YK2025056"],"award-info":[{"award-number":["YK2025056"]}],"id":[{"id":"https:\/\/ror.org\/00cs48e65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Yancheng Science and Technology Plan Project","award":["YCBK2023029"],"award-info":[{"award-number":["YCBK2023029"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to develop a dynamic nomogram in which clinical indicators are integrated with magnetic resonance imaging (MRI) radiomics to predict axillary lymph node metastasis (ALNM) in patients with breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our retrospective study included 221 pathologically confirmed patients with breast cancer. Radiomic features were extracted from dynamic contrast-enhanced MRI (DCE-MRI) and fat-suppressed T2-weighted imaging (FS-T2WI) datasets. After feature screening, a support vector machine (SVM) algorithm was employed to establish radiomic models and calculate radiomic scores. Clinical independent predictors were identified through univariate and multivariate logistic regression analyses. A nomogram was established on the basis of the radiomic scores obtained with the optimal SVM model and clinically independent predictors, and it was subsequently transformed into a dynamic nomogram. Model performance was evaluated by the receiver operating characteristic curve and area under the curve (AUC). Shapley additive explanation (SHAP) was applied to interpret the contribution of clinical predictors. Calibration and decision curves were employed to assess nomogram performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The platelet-to-lymphocyte ratio (PLR), breast imaging reporting and data system (BI-RADS) classification, and ALN status on MRI were identified as independent predictors of ALNM (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). SHAP analysis identified PLR as the top contributor. The clinical model developed with the three predictors achieved AUCs of 0.845 and 0.706 in the training and validation cohorts, respectively. Among the SVM models, the DCE-MRI and FS-T2WI fusion sequence model outperformed the single-sequence models, with AUCs of 0.868 and 0.875, respectively, in the training and validation cohorts. When clinical predictors were incorporated into the fusion sequence model, the nomogram achieved AUC values of 0.930 and 0.928 in the training and validation cohorts. Decision curve analysis demonstrated that the nomogram has significant clinical value.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A nomogram model integrating MRI-derived radiomic scores, BI-RADS classification, ALN status, and PLR demonstrated good performance in predicting ALNM in patients with breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40644-026-01083-z","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:35:46Z","timestamp":1782477346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic nomogram for predicting axillary lymph node metastasis in breast cancer based on MRI analysis and the platelet-to-lymphocyte ratio (PLR)"],"prefix":"10.1186","volume":"26","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"1083_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"1083_CR2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1148\/radiol.2020192534","volume":"295","author":"JM Chang","year":"2020","unstructured":"Chang JM, Leung J, Moy L, Ha SM, Moon WK. Axillary nodal evaluation in breast cancer: state of the art. Radiology. 2020;295:500\u201315.","journal-title":"Radiology"},{"key":"1083_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40644-022-00450-w","volume":"22","author":"D Song","year":"2022","unstructured":"Song D, Yang F, Zhang Y, Guo Y, Qu Y, Zhang X, et al. Dynamic contrast-enhanced MRI radiomics nomogram for predicting axillary lymph node metastasis in breast cancer. Cancer Imaging. 2022;22:17.","journal-title":"Cancer Imaging"},{"key":"1083_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.acra.2023.10.026","volume":"31","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li J, Zhang J, Yu Z, Jiang H. Radiomic nomogram for predicting axillary lymph node metastasis in patients with breast cancer. Acad Radiol. 2024;31:788\u201399.","journal-title":"Acad Radiol"},{"key":"1083_CR5","doi-asserted-by":"publisher","first-page":"21923","DOI":"10.1038\/s41598-025-08001-6","volume":"15","author":"Y Shen","year":"2025","unstructured":"Shen Y, Huang R, Zhang Y, Zhu J, Li Y. Prediction of axillary lymph node metastasis in triple negative breast cancer using MRI radiomics and clinical features. Sci Rep. 2025;15:21923.","journal-title":"Sci Rep"},{"key":"1083_CR6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.acra.2021.08.024","volume":"29","author":"C Militello","year":"2022","unstructured":"Militello C, Rundo L, Dimarco M, Orlando A, Woitek R, D\u2019Angelo I, et al. 3D DCE-MRI radiomic analysis for malignant lesion prediction in breast cancer patients. Acad Radiol. 2022;29:830\u201340.","journal-title":"Acad Radiol"},{"key":"1083_CR7","doi-asserted-by":"publisher","first-page":"9556880","DOI":"10.1155\/2022\/9556880","volume":"2022","author":"Z Wu","year":"2022","unstructured":"Wu Z, Gao S, Yao Y, Yi L, Wang J, Liu F. Predictive value of preoperative dynamic contrast-enhanced mri imaging features in breast cancer patients with postoperative recurrence time. Emerg Med Int. 2022;2022:9556880.","journal-title":"Emerg Med Int"},{"key":"1083_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441\u201346.","journal-title":"Eur J Cancer"},{"key":"1083_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H, Radiomics. Images are more than pictures, they are data. Radiology. 2016;278:563\u201377.","journal-title":"Radiology"},{"key":"1083_CR10","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.acra.2022.12.014","volume":"30","author":"M Jiang","year":"2023","unstructured":"Jiang M, Li CL, Luo XM, Chuan ZR, Chen RX, Jin CY. An MRI-based radiomics approach to improve breast cancer histological grading. Acad Radiol. 2023;30:1794\u2013804.","journal-title":"Acad Radiol"},{"key":"1083_CR11","doi-asserted-by":"publisher","first-page":"541849","DOI":"10.3389\/fonc.2020.541849","volume":"10","author":"N Mao","year":"2020","unstructured":"Mao N, Dai Y, Lin F, Ma H, Duan S, Xie H, et al. Radiomics nomogram of DCE-MRI for the prediction of axillary lymph node metastasis in breast cancer. Front Oncol. 2020;10:541849.","journal-title":"Front Oncol"},{"key":"1083_CR12","doi-asserted-by":"publisher","first-page":"1219071","DOI":"10.3389\/fonc.2023.1219071","volume":"13","author":"S Lai","year":"2023","unstructured":"Lai S, Liang F, Zhang W, Zhao Y, Li J, Zhao Y, et al. Evaluation of molecular receptors status in breast cancer using an mpMRI-based feature fusion radiomics model: mimicking radiologists\u2019 diagnosis. Front Oncol. 2023;13:1219071.","journal-title":"Front Oncol"},{"key":"1083_CR13","doi-asserted-by":"publisher","first-page":"105311","DOI":"10.1016\/j.ebiom.2024.105311","volume":"107","author":"Z Li","year":"2024","unstructured":"Li Z, Gao J, Zhou H, Li X, Zheng T, Lin F, et al. Multiregional dynamic contrast-enhanced MRI-based integrated system for predicting pathological complete response of axillary lymph node to neoadjuvant chemotherapy in breast cancer: multicentre study. EBioMedicine. 2024;107:105311.","journal-title":"EBioMedicine"},{"key":"1083_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12885-024-11931-5","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Song M, Yang Z, Huang X, Lin Y, Yang H. Healthy lifestyles, systemic inflammation and breast cancer risk: a mediation analysis. BMC Cancer. 2024;24:208.","journal-title":"BMC Cancer"},{"key":"1083_CR15","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.2147\/IJGM.S411592","volume":"16","author":"L Tong","year":"2023","unstructured":"Tong L, Wang S, Zhang R, Wu Y, Xu D, Chen L. High levels of SII and PIV are the risk factors of axillary lymph node metastases in breast cancer: a retrospective study. Int J Gen Med. 2023;16:2211\u201318.","journal-title":"Int J Gen Med"},{"key":"1083_CR16","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.21873\/anticanres.14202","volume":"40","author":"K Takada","year":"2020","unstructured":"Takada K, Kashiwagi S, Asano Y, Goto W, Kouhashi R, Yabumoto A, et al. Prediction of sentinel lymph node metastasis using the platelet-to-lymphocyte ratio in T1 breast cancer. Anticancer Res. 2020;40:2343\u201349.","journal-title":"Anticancer Res"},{"key":"1083_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3233\/CBM-220260","volume":"38","author":"H Wang","year":"2023","unstructured":"Wang H, Yu J, Shen W, Zhao H, Cui J, Gao B. The ratio of lymphocyte\/red blood cells and platelets\/lymphocytes are predictive biomarkers for lymph node metastasis in patients with breast cancer. Cancer Biomark. 2023;38:595\u2013602.","journal-title":"Cancer Biomark"},{"key":"1083_CR18","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1200\/JCO.2005.03.3225","volume":"24","author":"G Houvenaeghel","year":"2006","unstructured":"Houvenaeghel G, Nos C, Mignotte H, Classe JM, Giard S, Rouanet P, et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement\u2013Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol. 2006;24:1814\u201322.","journal-title":"J Clin Oncol"},{"key":"1083_CR19","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.17305\/bb.2025.12475","volume":"25","author":"Y Fan","year":"2025","unstructured":"Fan Y, Sun K, Xiao Y, Zhong P, Meng Y, Yang Y, et al. Deep learning predicts HER2 status in invasive breast cancer from multimodal ultrasound and MRI. Biomol Biomed. 2025;25:2243\u201351.","journal-title":"Biomol Biomed"},{"key":"1083_CR20","doi-asserted-by":"publisher","first-page":"6729473","DOI":"10.1155\/2022\/6729473","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li X, Zhu L, Zhao Z, Wang T, Zhang X, et al. Preoperative prediction of axillary lymph node metastasis in breast cancer based on intratumoral and peritumoral DCE-MRI radiomics nomogram. Contrast Media Mol Imaging. 2022;2022:6729473.","journal-title":"Contrast Media Mol Imaging"},{"key":"1083_CR21","doi-asserted-by":"publisher","first-page":"8211","DOI":"10.21037\/qims-24-558","volume":"14","author":"PQ Wu","year":"2024","unstructured":"Wu PQ, Guo FL, Wang J, Gao Y, Feng ST, Chen SL, et al. Development and validation of a dynamic contrast-enhanced magnetic resonance imaging-based habitat and peritumoral radiomic model to predict axillary lymph node metastasis in patients with breast cancer: a retrospective study. Quant Imaging Med Surg. 2024;14:8211\u201326.","journal-title":"Quant Imaging Med Surg"},{"key":"1083_CR22","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.acra.2019.11.004","volume":"27","author":"H Tan","year":"2020","unstructured":"Tan H, Gan F, Wu Y, Zhou J, Tian J, Lin Y, et al. Preoperative prediction of axillary lymph node metastasis in breast carcinoma using radiomics features based on the fat-suppressed T2 sequence. Acad Radiol. 2020;27:1217\u201325.","journal-title":"Acad Radiol"},{"key":"1083_CR23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3348\/kjr.2019.0568","volume":"21","author":"BH Choi","year":"2020","unstructured":"Choi BH, Baek HJ, Ha JY, Ryu KH, Moon JI, Park SE, et al. Feasibility study of synthetic diffusion-weighted MRI in patients with breast cancer in comparison with conventional diffusion-weighted MRI. Korean J Radiol. 2020;21:1036\u201344.","journal-title":"Korean J Radiol"},{"key":"1083_CR24","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s00330-017-5005-7","volume":"28","author":"Y Dong","year":"2018","unstructured":"Dong Y, Feng Q, Yang W, Lu Z, Deng C, Zhang L, et al. Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol. 2018;28:582\u201391.","journal-title":"Eur Radiol"},{"key":"1083_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13244-021-01034-1","volume":"12","author":"C Chen","year":"2021","unstructured":"Chen C, Qin Y, Chen H, Zhu D, Gao F, Zhou X. A meta-analysis of the diagnostic performance of machine learning-based MRI in the prediction of axillary lymph node metastasis in breast cancer patients. Insights Imaging. 2021;12:156.","journal-title":"Insights Imaging"},{"key":"1083_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.acra.2022.04.004","volume":"30","author":"O Lafc\u0131","year":"2023","unstructured":"Lafc\u0131 O, Celepli P, Seher \u00d6P, Ko\u015far PN. DCE-MRI radiomics analysis in differentiating Luminal A and Luminal B breast cancer molecular subtypes. Acad Radiol. 2023;30:22\u20139.","journal-title":"Acad Radiol"},{"key":"1083_CR27","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1007\/s12094-024-03814-9","volume":"27","author":"O Fiste","year":"2025","unstructured":"Fiste O, Mavrothalassitis E, Kokkalis A, Anagnostakis M, Gomatou G, Kontogiannis A, et al. Inflammation-related biomarkers as predictors of pathological complete response in early-stage breast cancer. Clin Transl Oncol. 2025;27:2453\u201360.","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"1083_CR28","first-page":"3233","volume":"14","author":"D Song","year":"2022","unstructured":"Song D, Li X, Zhang X. Expression and prognostic value of ratios of platelet lymphocyte, neutrophil lymphocyte and lymphocyte monocyte in breast cancer patients. Am J Transl Res. 2022;14(5):3233\u201339.","journal-title":"Am J Transl Res"},{"key":"1083_CR29","doi-asserted-by":"publisher","first-page":"1658571","DOI":"10.3389\/fimmu.2025.1658571","volume":"16","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Xu H, Ma B, Dong C. Prognostic value of platelet to lymphocyte ratio (PLR) in breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis. Front Immunol. 2025;16:1658571.","journal-title":"Front Immunol"},{"key":"1083_CR30","doi-asserted-by":"publisher","first-page":"e74874","DOI":"10.1136\/bmjopen-2023-074874","volume":"13","author":"X Qi","year":"2023","unstructured":"Qi X, Chen J, Wei S, Ni J, Song L, Jin C, et al. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis. BMJ Open. 2023;13:e74874.","journal-title":"BMJ Open"},{"key":"1083_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/03936155221118098","volume":"37","author":"Z Gong","year":"2022","unstructured":"Gong Z, Xin R, Li L, Lv L, Wu X. Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis. Int J Biol Markers. 2022;37:339\u201348.","journal-title":"Int J Biol Markers"},{"key":"1083_CR32","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.7150\/jca.25691","volume":"9","author":"R Yang","year":"2018","unstructured":"Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis. J Cancer. 2018;9:3295\u2013302.","journal-title":"J Cancer"},{"key":"1083_CR33","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/bjc.2013.508","volume":"109","author":"JP V\u00e4yrynen","year":"2013","unstructured":"V\u00e4yrynen JP, Tuomisto A, Klintrup K, M\u00e4kel\u00e4 J, Karttunen TJ, M\u00e4kinen MJ. Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer. 2013;109:1839\u201347.","journal-title":"Br J Cancer"},{"key":"1083_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12957-020-01952-2","volume":"18","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhao W, Yu Y, Qi X, Song L, Zhang C, et al. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World J Surg Oncol. 2020;18:191.","journal-title":"World J Surg Oncol"},{"key":"1083_CR35","doi-asserted-by":"publisher","first-page":"102144","DOI":"10.1016\/j.clgc.2024.102144","volume":"22","author":"A Salari","year":"2024","unstructured":"Salari A, Ghahari M, Bitaraf M, Fard ES, Haddad M, Momeni SA, et al. Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy. Clin Genitourin Cancer. 2024;22:102144.","journal-title":"Clin Genitourin Cancer"},{"key":"1083_CR36","doi-asserted-by":"publisher","first-page":"e12917","DOI":"10.1111\/eci.12917","volume":"48","author":"C Tian","year":"2018","unstructured":"Tian C, Song W, Tian X, Sun Y. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis. Eur J Clin Invest. 2018;48:e12917.","journal-title":"Eur J Clin Invest"},{"key":"1083_CR37","doi-asserted-by":"publisher","first-page":"757111","DOI":"10.3389\/fonc.2021.757111","volume":"11","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Yang L, Shen H. Value of the application of CE-MRI radiomics and machine learning in preoperative prediction of sentinel lymph node metastasis in breast cancer. Front Oncol. 2021;11:757111.","journal-title":"Front Oncol"},{"key":"1083_CR38","doi-asserted-by":"publisher","first-page":"10439","DOI":"10.2147\/CMAR.S272420","volume":"12","author":"W Chen","year":"2020","unstructured":"Chen W, Wang C, Fu F, Yang B, Chen C, Sun Y. A model to predict the risk of lymph node metastasis in breast cancer based on clinicopathological characteristics. Cancer Manag Res. 2020;12:10439\u201347.","journal-title":"Cancer Manag Res"},{"issue":"Suppl 2","key":"1083_CR39","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.acra.2023.05.025","volume":"30","author":"SE Song","year":"2023","unstructured":"Song SE, Woo OH, Cho Y, Cho KR, Park KH, Kim JW. Prediction of axillary lymph node metastasis in early-stage triple-negative breast cancer using multiparametric and radiomic features of breast MRI. Acad Radiol. 2023;30(Suppl 2):S25\u201337.","journal-title":"Acad Radiol"},{"key":"1083_CR40","doi-asserted-by":"publisher","first-page":"e2028086","DOI":"10.1001\/jamanetworkopen.2020.28086","volume":"3","author":"Y Yu","year":"2020","unstructured":"Yu Y, Tan Y, Xie C, Hu Q, Ouyang J, Chen Y, et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw Open. 2020;3:e2028086.","journal-title":"JAMA Netw Open"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01083-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01083-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01083-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:23:58Z","timestamp":1790087038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01083-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01083-z","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Yancheng First People\u2019s Hospital (2022-k135), and was conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"135"}}